Intas Biopharma: A Leading Player in Global Biosimilars

Intas Biopharma: A Global Leader in Biosimilars

Intas Biopharma is a leading global biosimilars company with a strong presence in over 80 countries. The company has a wide portfolio of biosimilars across various therapeutic areas, including oncology, immunology, and metabolic disorders. Intas Biopharma is committed to providing high-quality, affordable biosimilars to patients around the world.

Key Highlights of Intas Biopharma

• 80+ countries - Intas Biopharma has a global presence in over 80 countries.
• 20+ biosimilars - The company has a wide portfolio of over 20 biosimilars across various therapeutic areas.
• 15+ years of experience - Intas Biopharma has over 15 years of experience in the development and manufacturing of biosimilars.
• 10+ manufacturing facilities - The company has over 10 manufacturing facilities located around the world.
• $2 billion in revenue - Intas Biopharma generated over $2 billion in revenue in 2021.

Therapeutic Areas of Focus

Intas Biopharma focuses on the development and manufacturing of biosimilars in the following therapeutic areas:

• Oncology
• Immunology
• Metabolic disorders

The company has a strong pipeline of biosimilars in development, including biosimilars for cancer, autoimmune diseases, and diabetes.

Commitment to Quality and Affordability

Intas Biopharma is committed to providing high-quality, affordable biosimilars to patients around the world. The company's biosimilars are manufactured in state-of-the-art facilities and meet the highest quality standards. Intas Biopharma also offers a variety of programs to help patients access its biosimilars, including patient assistance programs and co-pay assistance programs.

Innovation and Partnerships

Intas Biopharma is committed to innovation and collaborates with leading research institutions and universities around the world. The company is also investing in new technologies to develop next-generation biosimilars.

Conclusion

Intas Biopharma is a leading global biosimilars company with a strong commitment to providing high-quality, affordable biosimilars to patients around the world. The company has a wide portfolio of biosimilars across various therapeutic areas and is investing in new technologies to develop next-generation biosimilars. Intas Biopharma is a trusted partner for healthcare providers and patients around the world.

Additional Information

• Website: www.intasbiopharma.com
• Email: [email protected]
• Phone: +1-800-555-1212